CTOs on the Move

Attune Pharmaceuticals

www.attunepharma.com

 
Attune Pharmaceuticals is a private biotechnology company focused on discovering and developing novel orally-administered small-molecule therapeutics for the treatment of rare diseases.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Attune Pharmaceuticals raised $23M on 01/23/2019
Attune Pharmaceuticals raised $299M on 01/23/2019

Similar Companies

PHASTAR

PHASTAR is a specialist biometrics contract research organization offering statistical consulting, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements and preferred partnerships. Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilizes internal processes designed to guarantee optimal quality, inspired by 4,000 years accumulated technical experience across the company. PHASTAR is headquartered in London (UK) and North Carolina (US) and has 14 offices worldwide.

Groups

Groups Recover Together offers medication-assisted treatment (MAT) for opioid addiction. We can prescribe Buprenorphine (Suboxone) medication you need today to stop feeling sick, and a supportive community you can rely on to help you to succeed.

Brightstone Transitions

Brightstone specializes in creating a customized support program for young people needing help through mentoring. Brightstone uses an action oriented approach that creates learning opportunities through real life situations. Our participants move beyon...

Dyancon

Dyancon is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

illumiPure

illumiPure’s patented Air Guardian and CleanWhite product solutions provide continuous and powerful disinfection to safely eradicate surface and air pathogens, as well as viruses, including SARS-CoV-2, the virus that causes COVID-19, while continuously...